CRXT logo

CRXT Cash From Operations

Annual CFO

-$43.79 M
-$2.21 M-5.31%

December 31, 2021

Summary

Performance

1-Year Change

-5.31%

3-Year Change

-5.31%

5-Year Change

-5.31%

15-Year Change

-5.31%

CRXT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$41.58 M

3-Year Low

-$43.79 M
CRXT annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CRXT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CRXT next annual earnings announcement has not yet been scheduled

OtherCRXTcash flowmetrics:

Annual CFI

-$25.00 K
CRXT annual cash flow from investing activities is -$25.00 thousand

Annual CFF

$62.99 M
CRXT annual cash flow from financing activities is $62.99 million

Annual FCF

-$43.81 M
CRXT annual free cash flow is -$43.81 million

Annual CAPEX

$25.00 K
CRXT annual capital expenditures is $25.00 thousand

Quarterly CFO

-$17.50 M
-$233.00 K-1.35%

June 30, 2022

Summary

Performance

3-Month Change

-1.35%

1-Year Change

-17.51%

3-Year Change

-

5-Year Change

-

CRXT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.04 M

3-Year Low

-$17.50 M
CRXT quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CRXT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CRXT next earnings announcement has not yet been scheduled

OtherCRXTcash flowmetrics:

Quarterly CFI

$0.00
CRXT quarterly cash flow from investing activities is $0.00

Quarterly CFF

$27.54 M
CRXT quarterly cash flow from financing activities is $27.54 million

Quarterly FCF

-$17.50 M
CRXT quarterly free cash flow is -$17.50 million

Quarterly CAPEX

$0.00
CRXT quarterly capital expenditures is $0.00

TTM CFO

-$56.62 M
-$2.61 M-4.83%

June 30, 2022

Summary

Performance

3-Month Change

-4.83%

1-Year Change

-158.13%

3-Year Change

-

5-Year Change

-

CRXT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.04 M

3-Year Low

-$56.62 M
CRXT TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CRXT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CRXT next earnings announcement has not yet been scheduled

OtherCRXTcash flowmetrics:

TTM CFI

-$15.00 K
CRXT TTM cash flow from investing activities is -$15.00 thousand

TTM CFF

$65.53 M
CRXT TTM cash flow from financing activities is $65.53 million

TTM FCF

-$56.63 M
CRXT TTM free cash flow is -$56.63 million

TTM CAPEX

$15.00 K
CRXT TTM capital expenditures is $15.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CRXT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.3%-17.5%-158.1%
3 y3 years-5.3%--
5 y5 years-5.3%--

CRXT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+87.5%at low+29.3%at low
5 y5-year+5.3%at low+148.5%at low+704.0%at low
alltimeall time+5.3%at low+148.5%at low+704.0%at low

Clarus Therapeutics Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2022
-
-$17.50 M(+1.3%)
-$56.62 M(+4.8%)
Mar 2022
-
-$17.27 M(+85.0%)
-$54.01 M(+23.4%)
Dec 2021
-$43.79 M
-$9.33 M(-25.4%)
-$43.79 M(+27.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$12.52 M(-16.0%)
-$34.45 M(+57.1%)
Jun 2021
-
-$14.89 M(+111.5%)
-$21.93 M(+211.5%)
Mar 2021
-
-$7.04 M
-$7.04 M
Dec 2020
-$41.58 M
-
-

FAQ

  • What is Clarus Therapeutics Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Clarus Therapeutics Holdings?
  • What is Clarus Therapeutics Holdings annual CFO year-on-year change?
  • What is Clarus Therapeutics Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Clarus Therapeutics Holdings?
  • What is Clarus Therapeutics Holdings quarterly CFO year-on-year change?
  • What is Clarus Therapeutics Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Clarus Therapeutics Holdings?
  • What is Clarus Therapeutics Holdings TTM CFO year-on-year change?

What is Clarus Therapeutics Holdings annual cash flow from operations?

The current annual CFO of CRXT is -$43.79 M

What is the all time high annual CFO for Clarus Therapeutics Holdings?

Clarus Therapeutics Holdings all-time high annual cash flow from operations is -$41.58 M

What is Clarus Therapeutics Holdings annual CFO year-on-year change?

Over the past year, CRXT annual cash flow from operations has changed by -$2.21 M (-5.31%)

What is Clarus Therapeutics Holdings quarterly cash flow from operations?

The current quarterly CFO of CRXT is -$17.50 M

What is the all time high quarterly CFO for Clarus Therapeutics Holdings?

Clarus Therapeutics Holdings all-time high quarterly cash flow from operations is -$7.04 M

What is Clarus Therapeutics Holdings quarterly CFO year-on-year change?

Over the past year, CRXT quarterly cash flow from operations has changed by -$2.61 M (-17.51%)

What is Clarus Therapeutics Holdings TTM cash flow from operations?

The current TTM CFO of CRXT is -$56.62 M

What is the all time high TTM CFO for Clarus Therapeutics Holdings?

Clarus Therapeutics Holdings all-time high TTM cash flow from operations is -$7.04 M

What is Clarus Therapeutics Holdings TTM CFO year-on-year change?

Over the past year, CRXT TTM cash flow from operations has changed by -$34.69 M (-158.13%)